Add comprehensive articles on Vascular Dementia and Wallerian Degeneration

- Created a detailed article for Vascular Dementia covering key facts, terminology, imaging findings, differential diagnoses, pathology, clinical issues, and diagnostic checklist.
- Developed an extensive article on Wallerian Degeneration including key facts, terminology, imaging features, differential diagnoses, pathology, clinical issues, and diagnostic checklist.
This commit is contained in:
Ross
2025-10-17 22:11:27 +01:00
parent efbfd301f0
commit 2f8df5f820
104 changed files with 6295 additions and 1469 deletions
@@ -0,0 +1,206 @@
---
title: "Pituitary Hyperplasia"
docid: "9696bc9e-f00b-4fa7-aa67-f039efd8fbed"
breadcrumbs:
- "Brain"
- "Diagnosis"
- "Anatomy-Based Diagnoses"
- "Sella and Pituitary"
- "Miscellaneous"
- "Pituitary Hyperplasia"
---
# KEY FACTS
- ## Terminology
- Normal maximal pituitary height varies with age, sex
- Pregnant/lactating females: 12 mm
- Young menstruating females: 10 mm
- Males, postmenopausal females: 8 mm
- Infants, children: 6 mm
- Nonphysiologic hyperplasia seen with
- Hypothyroidism, Addison disease, or other end-organ failure
- Some neuroendocrine neoplasms
- ## Imaging
- Enlarged homogeneously enhancing pituitary gland with convex superior margin
- Best technique: High-resolution MR
- Sagittal/coronal T1; coronal T2
- Dynamic coronal T1WI
- Postcontrast T1 FS sagittal/coronal T1
- 3- to 4-mm slice thickness
- ## Top Differential Diagnoses
- Pituitary macroadenoma
- Pituitary microadenoma
- Lymphocytic hypophysitis
- Venous congestion (intracranial hypotension, dural arteriovenous fistula)
- ## Pathology
- Normal: Physiologic hyperplasia in pregnancy, lactation
- Abnormal: Longstanding untreated primary hypothyroidism
- Loss of thyroxine feedback inhibition, overproduction of thyrotropin-releasing hormone
- Secondary pituitary hyperplasia
- Orthotopic or ectopic production of hypothalamic-releasing hormones
- Orthotopic: Response to end-organ failure
- Ectopic: Related to neuroendocrine tumors
# TERMINOLOGY
- ## Definitions
- Upper limit of normal pituitary height varies with age, sex
- Pregnant/lactating females: 12 mm
- Young menstruating females: 10 mm
- Males, postmenopausal females: 8 mm
- Infants, children: 6 mm
- Nonphysiologic pituitary hyperplasia seen with
- Longstanding untreated primary hypothyroidism
- Addison disease, end-organ failure, some neuroendocrine neoplasms
# IMAGING
- ## General Features
- ### Best diagnostic clue
- Enlarged homogeneously enhancing pituitary gland with convex superior margin
- > 10 mm up to 15 mm
- May be nodular, mimic pituitary adenoma
- ### Location
- Sella; may extend into suprasellar region, compress adjacent structures
- ## CT Findings
- ### NECT
- Noncalcified pituitary gland enlargement
- ### CECT
- Homogeneous enhancement
- ## MR Findings
- ### T1WI
- Isointense with remainder of pituitary gland
- ### T2WI
- Isointense with remainder of pituitary gland
- ### T1WI C+
- Diffusely enhancing gland is typical
- Rare = may cause focal nodular enlargement
- Dynamic MR: Enhances similar to remainder of gland
- ## Imaging Recommendations
- ### Best imaging tool
- MR with 3- to 4-mm slices, small FOV
- ### Protocol advice
- Sagittal/coronal T1; coronal T2
- Dynamic enhanced coronal T1WI
- Postcontrast T1 FS sagittal/coronal
# DIFFERENTIAL DIAGNOSIS
- [Pituitary Macroadenoma](/document/pituitary-microadenoma/283f3068-d369-4f79-bf01-0f2b82c6e49b)
- May be indistinguishable
- Rare: May occur secondary to primary hypothyroidism
- [Pituitary Microadenoma](/document/pituitary-microadenoma/283f3068-d369-4f79-bf01-0f2b82c6e49b)
- May be indistinguishable
- Enhances slower than normal gland on dynamic study
- [Lymphocytic Hypophysitis](/document/lymphocytic-hypophysitis/f30774c3-cbd0-4ab3-b3d1-e0574106db1f)
- Enlarged gland &/or stalk
- Pregnant or postpartum females
- ## Venous Congestion
- [Can occur with intracranial hypotension](/document/intracranial-hypotension/818a7972-1032-4d3e-a65a-97c494334aac)
- [Dural arteriovenous fistulas](/document/dural-av-fistula/628fd160-1e22-4b55-83f9-c25464d05bd6)
# PATHOLOGY
- ## General Features
- ### Etiology
- Normal: Physiologic hyperplasia in pregnancy, lactation
- Longstanding untreated primary hypothyroidism
- Loss of thyroxine feedback inhibition, overproduction of thyrotropin-releasing hormone
- Secondary pituitary hyperplasia
- Orthotopic or ectopic production of hypothalamic-releasing hormones
- Orthotopic: Response to end-organ failure
- Ectopic: Related to neuroendocrine tumors
- ## Microscopic Features
- Nodular hyperplasia characterized by marked expansion of acini, architectural distortion
- Diffuse hyperplasia requires formal cell count
- Growth hormone cell hyperplasia usually diffuse, occurs with neuroendocrine tumors
- Pancreatic islet cell tumor, pheochromocytoma, and bronchial and thyroid carcinoid tumors
- Associated with McCune-Albright syndrome, multiple endocrine neoplasia syndrome, and Carney complex
- Prolactin cell hyperplasia: Diffuse > nodular
- May be seen with pregnancy and lactation, estrogen treatment, primary hypothyroidism, Cushing disease
- Corticotroph hyperplasia: Nodular or diffuse
- Associated with Cushing disease, neuroendocrine tumors, untreated Addison disease
- Thyrotroph hyperplasia
- Longstanding primary hypothyroidism, may have associated prolactin hyperplasia
- Gonadotroph hyperplasia (e.g., Turner, Klinefelter syndromes)
# CLINICAL ISSUES
- ## Presentation
- ### Most common signs/symptoms
- Varies with cell type of hyperplasia
- ## Demographics
- ### Age
- Typically adults (rare in children)
- ### Sex
- No predilection
- ## Treatment
- If related to hypothyroidism, regression after thyroid hormone therapy common
- Treat end-organ failure or neuroendocrine tumor
# DIAGNOSTIC CHECKLIST
- ## Consider
- Hyperplasia may mimic adenoma
- Clinical information can help differentiate
- If imaging looks like adenoma in prepubescent male, consider end-organ failure
f1e3a750-ebdd-439c-8134-0efe1099c891